Vulnerable period in heart failure: a window of opportunity for the optimization of treatment – a statement by Mexican experts

Vulnerable period in heart failure: a window of opportunity for the optimization of treatment – a statement by Mexican experts

Acute heart failure (HF) is associated with poor prognosis. After the acute event, there is a vulnerable period during which the patient has a marked risk of readmission or death. Therefore, early optimization of treatment is mandatory during the vulnerable period. The objective of this article is t...

Full description

Bibliographic Details
Main Authors: José Antonio Magaña Serrano, José Angel Cigarroa López, Adolfo Chávez Mendoza, Juan Betuel Ivey-Miranda, Genaro Hiram Mendoza Zavala, Luis Olmos Domínguez, Sergio Armando Chávez Leal, José Ernesto Pombo Bartelt, Eduardo Heberto Herrera-Garza, Gerardo Mercado Leal, Rodolfo Parra Michel, Luisa Fernanda Aguilera Mora, Patricia Lenny Nuriulu Escobar
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2024-01-01
Series:Drugs in Context
Subjects:
acute
decompensation
heart failure
treatment
vulnerable period
Online Access:https://www.drugsincontext.com/vulnerable-period-in-heart-failure-a-window-of-opportunity-for-the-optimization-of-treatment-a-statement-by-mexican-experts/

Internet

https://www.drugsincontext.com/vulnerable-period-in-heart-failure-a-window-of-opportunity-for-the-optimization-of-treatment-a-statement-by-mexican-experts/

Similar Items